14.91
+0.54(+3.76%)
Currency In USD
| Previous Close | 14.37 |
| Open | 14.43 |
| Day High | 15.75 |
| Day Low | 14.09 |
| 52-Week High | 24.5 |
| 52-Week Low | 8.89 |
| Volume | 453,145 |
| Average Volume | 474,681 |
| Market Cap | 646.44M |
| PE | -11.65 |
| EPS | -1.28 |
| Moving Average 50 Days | 13.42 |
| Moving Average 200 Days | 15.73 |
| Change | 0.54 |
Beta Bionics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
IRVINE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Hea
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire Inc.
Apr 16, 2025 8:05 PM GMT
IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2025 financial result
Beta Bionics to Host Investor Event on June 22, 2025
GlobeNewswire Inc.
Apr 09, 2025 11:30 AM GMT
IRVINE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it will host an investor event on Sunday, J